Rodent hepatocarcinogenic peroxisome proliferators induce proliferation of rat hepatocytes in primary mixed cultures with rat liver epithelial cells.
The effect of two members of the hypolipidemic medicine class of hepatocarcinogenic peroxisome proliferators on proliferation of hepatocytes in primary mixed cultures with liver epithelial cells was studied. Rat hepatocytes present in primary mixed cultures with rat liver epithelial cells were maintained for 3 months retaining their differentiated characteristics and proliferative potential. Hepatocyte clusters in mixed cultures stained positive for albumin, indicating that they retained some metabolic functions. Furthermore, in mixed cultures exposed to 0.2 mM clofibric acid or ciprofibrate for 3 months, hepatocytes were engaged in proliferation as shown by the expression of proliferating cell nuclear antigen (PCNA) and the presence of mitotic figures. This in vitro system could be useful to obtain more information about responses of liver cells during prolonged exposure to peroxisome proliferators.
Perrone
C E
CE
Department of Pathology and Toxicology, American Health Foundation, Valhalla, NY 10595, USA.
Williams
G M
GM
D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects; D002995:Clofibric Acid / Q000031:analogs & derivatives* / Q000494:pharmacology*; D004847:Epithelial Cells / Q000166:cytology; D058607:Fibric Acids; D008099:Liver / Q000166:cytology / Q000187:drug effects*; D008297:Male; D008830:Microbodies / Q000187:drug effects*; D008934:Mitogens; D051381:Rats; D011916:Rats, Inbred F344
D000924:Anticholesteremic Agents; D058607:Fibric Acids; D008934:Mitogens; D002995:Clofibric Acid; C019304:ciprofibrate